Clinical Trials

Advanced Solid Tumor (Phase 1)

NCT05620017 2026-02-09

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

182 enrolled

Advanced Solid Tumors

NCT06792552 2026-01-29

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

414 enrolled

Advanced Solid Tumors

NCT06298058 2026-01-07

A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

144 enrolled

Advanced Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

67 enrolled

Solid Tumor

NCT07252414 2026-01-05

GenSci143 in Participants With Advanced Solid Tumors

180 enrolled

Advanced Solid Tumors

NCT07251166 2025-12-24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

170 enrolled

Advanced Solid Tumors

NCT07087197 2025-12-08

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

90 enrolled

Metastatic Solid Tumors

NCT06428331 2025-12-05

A Study of SKB518 in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumors

NCT06826040 2025-12-05

SKB445 for Injection in Solid Tumors

126 enrolled

Advanced Solid Tumors

NCT06238401 2025-11-24

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

77 enrolled

Advanced Solid Tumors

NCT05367635 2025-11-17

A Study of SKB315 in Patients With Advanced Solid Tumors

246 enrolled

Advanced Solid Tumors

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

85 enrolled

Solid Tumors

NCT05109650 2025-08-12

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Phase 1 Terminated

13 enrolled

Phase 1 Active not recruiting

Advanced Solid Tumour

NCT05906537 2025-08-07

SKB410 for Injection in Solid Tumors

54 enrolled

Phase 1 Active not recruiting

Advanced Solid Tumors

NCT05879627 2025-07-30

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

250 enrolled

Advanced Solid Tumors

NCT06132828 2025-07-03

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

216 enrolled

Solid Tumor

NCT07045454 2025-07-01

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT04975958 2025-06-22

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

47 enrolled

Phase 1 Not yet recruiting

Locally Advanced Solid Tumor

NCT06885645 2025-04-03

First-In-Human Study in Participants With Advanced Solid Tumors

30 enrolled

Advanced Solid Tumors

NCT04998422 2025-03-13

A Study of HG381 Administered to Patients With Advanced Solid Tumors

57 enrolled

Advanced Solid Tumor

NCT01251562 2025-02-19

Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors

50 enrolled

Solid Tumors

NCT05414136 2024-12-24

Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

37 enrolled

Advanced Solid Tumor

NCT04638491 2024-06-10

Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients

32 enrolled

Phase 1 Active not recruiting

Advanced Solid Tumor

NCT05037149 2024-03-18

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

50 enrolled

Solid Tumor

NCT05877664 2024-03-06

Study of ZG0895.HCl in Patients With Advanced Solid Tumors

60 enrolled

Advanced Solid Tumor

NCT04190823 2023-11-27

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

63 enrolled

Solid Tumors

NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

135 enrolled

Solid Tumor

NCT05073484 2023-10-11

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

Phase 1 Terminated

13 enrolled

Advanced Solid Tumor

NCT04601285 2023-07-06

A Phase I Study of JS108 in Patients With Advanced Solid Tumors

Phase 1 Terminated

25 enrolled

Advanced Solid Tumors

NCT05848466 2023-05-08

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

109 enrolled

Advanced or Metastatic Solid Tumors

NCT05405621 2022-10-27

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

48 enrolled

Locally Advanced/Metastatic Solid Tumours

NCT05508620 2022-08-23

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

270 enrolled

Malignant Solid Tumors

NCT04811118 2022-01-31

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

27 enrolled

Advanced Solid Tumors

NCT05125523 2022-01-25

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

264 enrolled

Advanced Solid Tumors

NCT04673396 2020-12-21

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

36 enrolled

Solid Tumor

NCT04189211 2019-12-06

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

30 enrolled

HER2-Positive Solid Tumors

NCT03286296 2019-08-02

LZM009 to Treat Patients With Advanced Solid Tumors

30 enrolled

Solid Tumor

NCT01832298 2016-12-20

Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor

39 enrolled

Advanced Solid Tumor

NCT01163903 2015-07-15

Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours

24 enrolled

Advanced Solid Tumours

NCT00710125 2014-08-05

Safety Study of GPX-150 in Patients With Solid Tumors

27 enrolled